Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0567 per EA under NDC 00378018105. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378018105
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA018659On Market Since
10/24/1986
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.3392 (Nov 12, 2014) |
| All-time low | $0.0519 (Feb 19, 2014) |
| 52-week high | $0.0674 |
| 52-week low | $0.0552 |
| Median price | $0.0987 |
| Average price | $0.1372 |
| Largest weekly change | +492.3% (Oct 15, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0567 per EA (NDC 00378018105), effective Jun 24, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has risen 9.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Nov 28, 2013, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0519 (Feb 19, 2014) to a high of $0.3392 (Nov 12, 2014), with a median of $0.0987 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ALLOPURINOL 300 MG TABLET, but none are currently priced below it.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 00378018105) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification